Navigation Links
Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline
Date:2/13/2009

    New manufacturing facility opening in Second Quarter

TORONTO, Feb. 13 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (TSX:MBX) said today that despite a challenging year for the biopharmaceutical industry, it has maintained its focus and continued its advance toward the ultimate goal of sustained profitability. The Company was announcing results for the first quarter ended December 31, 2008.

In a news release today, William J. Gastle, CEO of Microbix said "the Company has improved the fundamentals of its core business and we are approaching major milestones in our product pipeline. We are waiting for the FDA to authorize release of Kinlytic inventory, our Urokinase product, we are in discussions with potential pharma partners for our Hunan (China) influenza vaccine business and we expect to provide guidance on the SST program as we near the end of the expanded sex specific protein investigation described in 2008."

    First Quarter Highlights

    Core Business

Growth was robust in the first quarter with sales improving over 50 per cent compared to the same quarter last year. "We exceeded our sales target in the first quarter," Mr. Gastle continued "and we are on a path to meet or exceed projections for this fiscal year. The Company will open its new facility in Mississauga, Ontario in March 2009 with significantly improved capacity.

VIRUSMAX(TM)

The Company is collaborating with a major firm to evaluate VIRUSMAX in their influenza vaccine manufacturing process in the second quarter. Preliminary results were promising and the evaluation has moved to the next phase at the partner's manufacturing facility.

We are pleased with the arrangement to form a manufacturing joint venture agreement to build and operate an influenza vaccine plant in China based on VIRUSMAX. We are making solid progress towards completing the pre-conditions that hav
'/>"/>

SOURCE Microbix Biosystems Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009
2. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
3. Beginners Luck, or Creative Artists of the First Rank? Epeius Biotechnologies Launches Rexin-G eBook Tutorial
4. Results of First Interim Efficacy Analysis for Riquent Phase 3 ASPEN Trial: Continuation of the Trial is Futile
5. First Multiple Dose Clinical Trial of TorreyPines Therapeutics Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated
6. Max Muscle Introduces First-Ever Probiotics Protein Bar
7. Pharmasset Reports Fiscal First Quarter 2009 Financial Results
8. Hoya Announces Third Quarter and the First Nine Months Financial Results for FY2008
9. Historic Seed Delivery Made in Illinois for First New Soybean Varieties With the Greater Yield Potential of Roundup Ready 2 Yield(TM)
10. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study
11. World's First Website for Patients to Share Diagnostic-Quality Medical Images
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... The winners of awards for supply chain ... Global Supply Chain Resiliency Council (GSCRC) at ... February 25th, 2015, at the Hyatt Regency in Santa ... together supply chain risk management and resiliency practitioners with ... through opportunities to collaborate, develop and share best practices, ...
(Date:3/3/2015)... Calif. , March 3, 2015 AtheroNova Inc. ... AtheroNova Operations, Inc., filed voluntary petitions under Chapter 11 of ... District of California , Santa ... 2015. The Company,s Chapter 11 cases are expected to be ... including a Bankruptcy Court supervised asset sale process, for all ...
(Date:3/3/2015)... 03, 2015 Research and Markets ... Jain PharmaBiotech,s new report "Personalized Medicine - ... , The aim of personalized ... right drug to the right patient and, in ... for a patient according to his/her genotype. This ...
(Date:3/3/2015)... --DNA Diagnostics Center (DDC), one of the largest commercial ... th anniversary today. Headed by President and CEO, ... company that focuses on DNA testing across multiple channels ... a significant portion of sales across international markets via ... Peter Vitulli acknowledges the anniversary of the company ...
Breaking Biology Technology:Global Supply Chain Resiliency Council Names Award Winners 2Global Supply Chain Resiliency Council Names Award Winners 3Global Supply Chain Resiliency Council Names Award Winners 4AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 2AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 3AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 4Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 2Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 3DNA Diagnostics Center, One of The World's Largest DNA Testing Labs, Celebrates Their 20th Anniversary 2DNA Diagnostics Center, One of The World's Largest DNA Testing Labs, Celebrates Their 20th Anniversary 3
... Inc. (OTCBB: MDRM) (the "Company") is pleased to announce ... its closing agreement to acquire all of the common ... Mobility Aids, Inc. is a Nevada-based Company whose strategic ... Bio-Pharma sector as well as scalable manufacturing in niche ...
... a professor of electrical and computer engineering and Director ... California, Santa Barbara, has been named winner of the ... (ESDA). "The ESDA research award is ... ideas that advance the field of electrostatic discharge. Professor ...
... ubiquitous. They occur in furrowed brows, planetary topology, the ... a gecko,s foot. In many cases, they are nature,s ... limited space. Scientists, mimicking nature, have long sought to ... smaller, more flexible electronic devices, fluid-carrying nanochannels or even ...
Cached Biology Technology:Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies 2Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies 3UCSB professor receives award for graphene electronics research 2Nanowrinkles, nanofolds yield strange hidden channels 2
(Date:2/12/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... for DISTRIBUTED METHOD AND SYSTEM TO IMPROVE ... further establishes NXT-ID,s position in the emerging "Internet of ... ability for multiple devices to collaborate with one another ...
(Date:2/5/2015)... 5, 2015  Marken is starting its 35 th ... launched a new marketing campaign to solidify its place ... new campaign focuses on First as a ... The first headline in the series, ... with its client,s priorities. Marken recognizes the need to ...
(Date:2/5/2015)... Conn. , Jan. 28, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... at the upcoming RedChip Global Online CEO Conference on ... Gino Pereira , CEO of NXT-ID ... its lead product, the Wocket smart wallet and its ...
Breaking Biology News(10 mins):NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Marken Launches New Patient-Centric Campaign 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3
... scientists has discovered that cannabinoids can cause some white blood ... of infection and inflammation. These findings, which appear in ... could have potential use in the development of novel anti-inflammatory ... include marijuana. These compounds bind to and activate the ...
... applications are potentially limitless. In the long term it ... prostheses to combat neurological disorders. What's more, it could ... neurons as their CPU. , Those applications are potentially ... new technology could enable very advanced and sophisticated drug ...
... penicillin, a byproduct of a fungal mold, was discovered in ... As reported Jan. 20 in the Journal of Chemistry and ... has developed a new method that may speed the ongoing ... By manipulating a single fungal protein, the team, led by ...
Cached Biology News:Researchers get neurons and silicon talking 2Mining for gems in the fungal genome 2Mining for gems in the fungal genome 3
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
Caliper offers a wide array of standard LabChip products designed to be used in combination with our AMS 90 and LabChip 3000 microfluidic platforms....
...
...
Biology Products: